4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001577014-26-000016
Director sold 2,586,928 shares at an average $25.20 ($65,184,894)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2026-08-13 | Sale 10b5-1 | −268,354 | $26.20 | $7,030,875 | 3,801,128 | I |
| Rhodes Jason P Director | 2026-08-13 | Sale 10b5-1 | −94,415 | $26.20 | $2,473,673 | 1,045,735 | I |
| Rhodes Jason P Director | 2026-08-13 | Sale 10b5-1 | −63,643 | $26.20 | $1,667,447 | 751,411 | I |
| Rhodes Jason P Director | 2026-08-14 | Sale 10b5-1 | −1,359,674 | $25.00 | $33,991,850 | 2,441,454 | I |
| Rhodes Jason P Director | 2026-08-14 | Sale 10b5-1 | −478,377 | $25.00 | $11,959,425 | 567,358 | I |
| Rhodes Jason P Director | 2026-08-14 | Sale 10b5-1 | −322,465 | $25.00 | $8,061,625 | 428,946 | I |
| Open-market sales · 2,586,928 sh · avg $25.20 · $65,184,894 | |||||||
Loading xslF345X06/form4-08172026_050803.xml…